Lrt Capital Management, LLC Novo Nordisk A S Transaction History

Lrt Capital Management, LLC

$127 Million
Q4 2024

A detailed history of Lrt Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lrt Capital Management, LLC holds 3,971 shares of NVO stock, worth $230,635. This represents 0.27% of its overall portfolio holdings.

Number of Shares

3,971

Previous 7,167 44.59%

Holding current value

$230,635

Previous $853,000 60.02%

% of portfolio

0.27%

Previous 0.81%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $271,660 - $383,647	-3,196 Reduced 44.59%	3,971 $341,000
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $853,374 - $1.04 Million	7,167 New	7,167 $853,000
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $1.13 Million - $1.36 Million	-12,894 Reduced 75.3%	4,230 $437,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $361,668 - $793,570	3,977 Added 30.25%	17,124 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $702,533 - $777,615	4,504 Added 52.11%	13,147 $2.13 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $2.34 Million - $2.81 Million	-17,683 Reduced 67.17%	8,643 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $246,017 - $324,656	2,399 Added 10.03%	26,326 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $1.39 Million - $1.7 Million	14,555 Added 155.3%	23,927 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1.72 Million - $2.02 Million	-16,616 Reduced 63.94%	9,372 $1.04 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $2.29 Million - $2.77 Million	-24,612 Reduced 48.64%	25,988 $2.89 Million
Q4 2021 Jan 18, 2022	BUY	$95.88 - $117.08 $4.85 Million - $5.92 Million	50,600 New	50,600 $5.67 Million

Others Institutions Holding NVO

# of Institutions

1,870

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $131B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lrt Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lrt Capital Management, LLC with notifications on news.

Account

Lrt Capital Management, LLC Novo Nordisk A S Transaction History